Back to search results

PORTAL-PTSD for Timely PTSD Diagnosis and Management

This study is testing a new approach called PORTAL-PTSD to help diagnose and manage Post-Traumatic Stress Disorder (PTSD) more quickly in primary care settings. It aims to improve how people are screened for PTSD, especially in areas with high rates of trauma like the South Side of Chicago. You might be able to join if you are 18 or older, have had a primary care visit in the last two years, and haven't been screened for PTSD in the past year. The study will measure how often people are screened for PTSD, how many are diagnosed, and how many receive treatment over two years. The current status of the study is unclear, and it plans to include about 17,000 participants.

Study design
This is an interventional study, meaning it tests a specific approach (PORTAL-PTSD). It plans to include about 17,000 participants.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for two years, with assessments every six months after the intervention.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06479447

Patient Outcome Reporting for Timely Assessments of Life With Post-Traumatic Stress Disorder

Recruiting
NAAges 18+InterventionalHealth services
University of Chicago
~17,000 participants
Updated 2025-11-10 on ClinicalTrials.gov
What's tested:PORTAL-PTSD

At a glance

Recruiting sites
2 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
PTSD screening rates
Measured over every 6 months post-intervention for 2 years
+3 more outcomes measured

Conditions

PTSD

Explore related trials

Post-Traumatic Stress Disorder

Where it's being run

2 sites across 1 states
Illinois2

Study leadership

  • Neda Laiteerapong, MD, MS · PRINCIPAL_INVESTIGATOR · University of Chicago

Who to contact

Ainur Kagarmanova, MS, MA
[email protected]
5742865712
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Age ≥18 years
Had an appointment at the study site in the last 24 months
Were not screened for PTSD in the last 12 months

Exclusion

N/A

What this trial measures

  • PTSD screening ratesevery 6 months post-intervention for 2 years

    Number and proportion of patients who were screened for PTSD, as determined by the validated Primary Care Post-Traumatic Stress Disorder screener (PC-PTSD-5).

  • PTSD diagnoses ratesevery 6 months post-intervention for 2 years

    Number and proportion of patients who screen positive for PTSD, as determined by the validated Primary Care Post-Traumatic Stress Disorder screener (PC-PTSD-5).

  • PTSD prescribed treatment ratesevery 6 months post-intervention for 2 years

    Treatment rate is measured as proportion of patients with PTSD and prescribed treatment out of total patients diagnosed with PTSD. Receipt of treatment is defined by completion of PCBH services or at least 3-months of therapy for PTSD for patients who choose to not receive PCBH services.

  • PTSD symptoms severityevery 6 months post-intervention for 2 years

    Patient-reported improvement in PTSD symptoms severity as measured by the 20-item Post-Traumatic Stress Disorder Checklist (PCL).